Sorafenib and bevacizumab combination targeted therapy in advanced neuroendocrine tumour: A phase II study of Spanish Neuroendocrine Tumour Group (GETNE0801)
- Castellano, D. 1
- Capdevila, J. 2
- Sastre, J. 3
- Alonso, V. 4
- Llanos, M. 5
- García-Carbonero, R. 6
- Manzano Mozo, J.L. 7
- Sevilla, I. 8
- Durán, I. 9
- Salazar, R. 10
- 1 Hospital Universtiario 12 de Octubre
-
2
Hospital Vall d'Hebron
info
-
3
Hospital Clínico San Carlos de Madrid
info
-
4
Hospital Miguel Servet
info
-
5
Hospital Universitario de Canarias
info
-
6
Hospital Universitario Virgen del Rocío
info
-
7
Hospital Universitari Germans Trias i Pujol
info
-
8
Hospital Universitario Virgen de la Victoria
info
- 9 Hospital Madrid-Norte Sanchinarro
-
10
Institute Catalá Oncología
info
Journal:
European Journal of Cancer
ISSN: 0959-8049
Year of publication: 2013
Volume: 49
Issue: 18
Pages: 3780-3787
Type: Article
Data source: Scopus